Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1046 per EA under NDC 59651039001. Its NADAC has been published 285 times since Mar 10, 2021.
FDA first approved this application on Feb 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651039001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078246FDA Approved
2/27/2009
TE Code
AB
On Market Since
2/21/2020
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 285 times since Mar 10, 2021, and over the history we have for it it has declined 61.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1046 per EA |
|---|---|
| All-time high | $0.2986 (May 12, 2021) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1212 |
| 52-week low | $0.1046 |
| Median price | $0.1467 |
| Average price | $0.1592 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 285 |
| Tracking since | Mar 10, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUSPIRONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1046 per EA (NDC 59651039001), effective Aug 19, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 61.5%. It has been tracked across 285 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Mar 10, 2021, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.2986 (May 12, 2021), with a median of $0.1467 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of BUSPIRONE HCL 7.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 59651039001) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.